View in EDS HTML Full Text PDF Full Text

A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12–24 Months.

Saved in:
Bibliographic Details
Title: A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12–24 Months.
Authors: Langley, Joanne M1 (AUTHOR), Nolan, Terry M2,3 (AUTHOR), Rämet, Mika4 (AUTHOR), Richmond, Peter C5,6 (AUTHOR), Filho, Nelson Rosário7 (AUTHOR), Haazen, Wouter8 (AUTHOR), Berg, Sara P H van den8 (AUTHOR), Williams, Kristi8 (AUTHOR), Bastian, Arangassery Rosemary8 (AUTHOR), Omoruyi, Edmund9 (AUTHOR), Durkin, Joanna Williams10 (AUTHOR), Salisch, Nadine8 (AUTHOR), Geet, Gunter Van11 (AUTHOR), Duijnhoven, Wilbert van11 (AUTHOR), Heijnen, Esther8 (AUTHOR) benoit.callendret@gmail.com, Callendret, Benoit8 (AUTHOR) benoit.callendret@gmail.com
Source: Open Forum Infectious Diseases. Sep2024, Vol. 11 Issue 9, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23288957
DOI:10.1093/ofid/ofae453